Cardiovascular risk and history of gestational hypertension in women of reproductive age

Cover Page

Cite item


In recent years, gestational hypertension, defined in accordance with the classification of the European Society of Cardiology (2011) as hypertension induced by pregnancy, occurring with or without proteinuria, developing after 20 weeks of pregnancy and resolving up to 42 days after delivery, is considered as a adverse prognostic factor in respect of development of cardiovascular diseases in the future and cardiovascular mortality. This review presents the results of various studies on the relationship of history of gestational hypertension with risk factors for cardiovascular disease, target organ damage, associated clinical conditions and cardiovascular risk in women, including those of reproductive age. Determination of the individual cardiovascular risk in women, especially in young women, is difficult due to the low sensitivity and specificity of the tests in this category of patients. In spite of the conducted studies and obtained experience regarding issues on the relationship of history of hypertension during pregnancy with cardiovascular risk, until now the origin and the contribution of the various forms of hypertensive disorders during pregnancy, including gestational hypertension, to the development of future cardiovascular disease is still unclear. Detection of the history of gestational hypertension will allow to more accurately assess the individual cardiovascular risk and administer an adequate range of therapeutic and preventive measures for women, including those of reproductive age, at an earlier stage.

About the authors

A R Shamkina

Kazan State Medical University

Author for correspondence.

A R Sadykova

Kazan State Medical University



  1. Вёрткин А.Л., Ткачёва О.Н., Васильева А.В. и др. Прогностическое значение артериальной гипертонии в период беременности. Рос. кард. ж. 2005; (4): 53-57.
  2. Вёрткин А.Л., Ткачёва О.Н., Васильева А.В. и др. Отдалённый прогноз при артериальной гипертензии в период гестации. Рос. кард. ж. 2004; (3): 42-46.
  3. Подзолкова Н.М., Подзолков В.И., Можарова Л.Г., Хомицкая Ю.В. Гормональный континуум женского здоровья: эволюция сердечно-сосудистого риска от менархе до менопаузы. Сердце. 2004; 3 (6): 276-279.
  4. Садыкова А.Р., Шамкина А.Р., Мустафина Г.Р. Оценка сердечно-сосудистого риска у женщин репродуктивного возраста в зависимости от наличия гестационной артериальной гипертензии в анамнезе. Казанский мед. ж. 2012; 93 (4): 564-569.
  5. Ткачёва О.Н., Барабашкина А.В., Разгуляева Н.Ф., Галяутдинова А.Ю. Изучение органопротективных и метаболических эффектов эналаприла при лечении артериальной гипертензии, сохраняющейся после родов. Трудный пациент. 2006; (3): 18-22.
  6. Чазова И.Е., Ратова Л.Г., Бойцов С.А., Небиеридзе Д.В. Диагностика и лечение артериальной гипертензии. Рекомендации Российского медицинского общества по артериальной гипертонии и Всероссийского научного общества кардиологов. Системные гипертензии. 2010; (3): 5-26.
  7. Шамкина А.Р., Садыкова А.Р. Ассоциация гестационной гипертензии в анамнезе с сердечно-сосудистым риском у женщин репродуктивного возраста. Монография. Казань: Ихлас. 2013; 103 с.
  8. Arnadottir G.A., Geirsson R.T., Arngrimsson R. et al. Cardiovascular death in women who had hypertension in pregnancy: a case-control study. BJOG. 2005; 112 (3): 286-292. doi: 10.1111/j.1471-0528.2004.00396.x
  9. Aukes A.M., de Groot J.C., Wiegman M.J. et al. Long-term cerebral imaging after pre-eclampsia. BJOG. 2012; 19 (9): 1117-1122. doi: 10.1111/j.1471-0528.2012.03406.x
  10. Aykas F., Solak Y., Erden A. et al. Persistence of cardiovascular risk factors in women with previous preeclampsia: a long-term follow-up study. J. Investig. Med. 2015; 63 (4): 641-645. doi: 10.1097/JIM.0000000000000189
  11. Ben-Ami S., Oron G., Ben-Haroush A. et al. Primary atherothrombotic occlusive vascular events in premenopausal women with history of adverse pregnancy outcome. Thromb. Res. 2010; 125 (2): 124-127. doi: 10.1016/j.thromres.2009.05.017
  12. Bhasin P., Kapoor S. Pregnancy complications and calculated cardiovascular risk in urban women: do we envisage an association? J. Urban Health. 2014; 91: 162-175. doi: 10.1007/s11524-013-9818-7
  13. Charlton F., Tooher J., Rye K.A., Hennessy A. Cardiovascular risk, lipids and pregnancy: preeclampsia and the risk of later life cardiovascular disease. Heart Lung Circ. 2014; 23 (3): 203-212. doi: 10.1016/j.hlc.2013.10.087
  14. Chobanian A.V., Bakris G.L., Black H.R. et al. The seventh report of the Joint National Commitee on prevention, detection, evaluation, and treatment of high blood pressure. The JNC VII report. JAMA. 2003; 289: 2560-2572. doi: 10.1001/jama.289.19.2560
  15. Cirillo P.M., Cohn B.A. Pregnancy complications and cardiovascular disease death: 50-year follow-up of the child health and development studies pregnancy cohort. Circulation. 2015; 132 (13): 1234-1242. doi: 10.1161/CIRCULATIONAHA.113.003901
  16. Cusimano M.C., Pudwell J., Roddy M. et al. The maternal health clinic: an initiative for cardiovascular risk identification in women with pregnancy-related complications. Am. J. Obstet. Gynecol. 2014; 210 (5): 1-9. doi: 10.1016/j.ajog.2013.12.001
  17. Dayer M.L., Vocat A., Ditisheim A., Pechère-Bertschi A. Renovascular prognosis of preeclampsia on the mother and the child. Rev. Med. Suisse. 2013; 397 (11): 628-630.
  18. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur. Heart J. 2011: 32 (24): 3147-3197. doi: 10.1093/eurheartj/ehr218
  19. Forest J.C., Girouard J., Massé J. et al. Early occurrence of metabolic syndrome after hypertension in pregnancy. Obstet. Gynecol. 2005; 105 (6): 1373-1380. doi: 10.1097/01.AOG.0000163252.02227.f8
  20. Fraser A., Nelson S.M., Macdonald-Wallis C. et al. Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and Children. Circulation. 2012; 125 (11): 367-380. doi: 10.1161/CIRCULATIONAHA.111.044784
  21. Garovic V.D., Hayman S.R. Hypertension in pregnancy: an emerging risk factor for cardiovascular disease. Nature Clin. Pract. Nephrol. 2007; 11 (3): 613-622. doi: 10.1038/ncpneph0623
  22. Garovic V.D., Bailey K.R., Boerwinkle E. et al. Hypertension in pregnancy as a risk factor for cardiovascular disease later in life. J. Hypertens. 2010; 28 (4): 826-833. doi: 10.1097/HJH.0b013e328335c29a
  23. Germain A.M., Romanik M.C., Guerra I. et al. Endothelial dysfunction: a link among preeclampsia, recurrent pregnancy loss, and future cardiovascular events? Hypertension. 2007; 49 (1): 90-95. doi: 10.1161/01.HYP.0000251522.18094.d4
  24. Hannaford P., Ferry S., Hirsch S. Cardiovascular sequelae of toxemia of pregnancy. Heart. 1997; 77: 154-158. doi: 10.1136/hrt.77.2.154
  25. Hashemi S., Ramezani Tehrani F., Mehrabi Y., Azizi F. Hypertensive pregnancy disorders as a risk factor for future cardiovascular and metabolic disorders (Tehran Lipid and Glucose Study). J. Obstet. Gynaecol. Res. 2013; 39 (5): 891-897. doi: 10.1111/j.1447-0756.2012.02069.x
  26. Haukkamaa L., Moilanen L., Kattainen A. et al. Pre-eclampsia is a risk factor of carotid artery atherosclerosis. Cerebrovasc. Dis. 2009; 27 (6): 599-607. doi: 10.1159/000216834
  27. Heida K.Y., Franx A., van Rijn B.B. et al. Earlier age of onset of chronic hypertension and type 2 diabetes mellitus after a hypertensive disorder of pregnancy or gestational diabetes mellitus. Hypertension. 2015; 66 (6): 1116-1122. doi: 10.1161/hypertensionaha.115.06005
  28. Hermes W., Franx A., van Pampus M.G. et al. Cardiovascular risk factors in women who had hypertensive disorders late in pregnancy: a cohort study. 10-Year cardiovascular event risks for women who experienced hypertensive disorders in late pregnancy: the HyRAS study. BMC Pregnancy Childbirth. 2010; 10: 28. doi: 10.1186/1471-2393-10-28
  29. Hoogsteder P.H., Krüse A.J., Sep S.J. et al. Electrocardiographic findings in women with a recent history of pre-eclampsia. Acta Obstet. Gynecol. Scand. 2012; 91 (3): 372-378. doi: 10.1111/j.1600-0412.2011.01328.x
  30. Leffert L.R., Clancy C.R., Bateman B.T. et al. Hypertensive disorders and pregnancy-related stroke: frequency, trends, risk factors, and outcomes. Obstet. Gynecol. 2015; 125 (1): 124-131. doi: 10.1097/AOG.0000000000000590
  31. Lindeberg S., Axelsson O., Jorner U. et al. Prospective controlled five-year follow up study of primiparas with gestational hypertension. Acta Obstet. Gynecol. Scand. 1988; 67: 605-609. doi: 10.3109/00016348809004272
  32. Luoto R., Kharazmi E., Whitley E. et al. Systolic hypertension in pregnancy and cardiovascular mortality: a 44-year follow-up study. Hypertens. Pregnancy. 2008; 27 (1): 87-94. doi: 10.1080/10641950701826810
  33. Lykke J.A., Langhoff-Roos J., Sibai B.M. et al. Hypertensive pregnancy disorders and subsequent cardiovascular morbidity and type 2 diabetes mellitus in the mother. Hypertension. 2009; 53 (6): 944-951. doi: 10.1161/HYPERTENSIONAHA.109.130765
  34. MacDonald S.D., Ray J., Teo K. et al. Measures of cardiovascular risk and subclinical atherosclerosis in a cohort of women with a remote history of preeclampsia. Atherosclerosis. 2013; 229 (1): 234-239. doi: 10.1016/j.atherosclerosis.2013.04.020
  35. MacDonald S.E., Walker M., Ramshaw H. et al. Hypertensive disorders of pregnancy and long-term risk of hypertension: what do Ontario prenatal care providers know, and what do they communicate? J. Obstet. Gynaecol. Can. 2007; 29 (9): 705-710. doi: 10.1016/S1701-2163(16)32601-9
  36. Magee L.A., Helewa M.E., Moutquin J.M. et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. This guideline has been reviewed and approved by the Hypertension Guideline Committee and approved by the Executive and Council of the Society of Obstetricians and Gynaecologists of Canada. JOGC. 2008; 30 (3, suppl.): 1-48.
  37. Magnussen E.B., Vatten L.J., Smith G.D., Romundstad P.R. Hypertensive disorders in pregnancy and subsequently measured cardiovascular risk factors. Obstet. Gynecol. 2009; 114 (5): 961-970. doi: 10.1097/AOG.0b013e3181bb0dfc
  38. Mahmud A., Jatoi M., Chee Y.R., Feely J. History of gestational hypertension is associated with the metabolic syndrome and masked hypertension but not arterial stiffness in women with essential hypertension. J. Clin. Hypertens. (Greenwich). 2008; 10 (1): 21-26. doi: 10.1111/j.1524-6175.2007.07400.x
  39. Malhotra M., Sharma J.B. et al. Eclampsia is not a sign of latent hypertension. BMJ. 2003; 20: 989-1000.
  40. Mangos G.J., Spaan J.J., Pirabhahar S., Brown M.A. Markers of cardiovascular disease risk after hypertension in pregnancy. J. Hypertens. 2012; 30 (2): 351-358. doi: 10.1097/HJH.0b013e32834e5ac7
  41. Männistö T., Mendola P., Vääräsmäki M. et al. Elevated blood pressure in pregnancy and subsequent chronic disease risk. Circulation. 2013; 127 (6): 681-690. doi: 10.1161/CIRCULATIONAHA.112.128751
  42. Melchiorre K., Sutherland G.R., Liberati M., Thilaganathan B. Preeclampsia is associated with persistent postpartum cardiovascular impairment. Hypertension. 2011; 58 (4): 709-715. doi: 10.1161/HYPERTENSIONAHA.111.176537
  43. Moreira L.B., Gus M., Nunes G. et al. Association between pregnancy-related hypertension and severity of hypertension. J. Hum. Hypertens. 2009; 23 (6): 415-419. doi: 10.1038/jhh.2008.140
  44. Robbins C.L., Dietz P.M., Bombard J., Valderrama A.L. Gestational hypertension: a neglected cardiovascular disease risk marker. Am. J. Obstet. Gynecol. 2011; 204 (4): 336, e1-9.
  45. Roberts J.M., Pearson G.D., Cutler J.A. National Heart Lung and Blood Institute. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertens. Pregnancy. 2003; 22 (2): 109-127. doi: 10.1081/PRG-120016792
  46. Romundstad P.R., Magnussen E.B., Smith G.D., Vatten L.J. Hypertension in pregnancy and later cardiovascular risk: common antecedents? Circulation. 2010; 122 (6): 579-584. doi: 10.1161/CIRCULATIONAHA.110.943407
  47. Sabour S., Franx A., Rutten A. et al. High blood pressure in pregnancy and coronary calcification. Hypertension. 2007; 49: 813-817. doi: 10.1161/01.HYP.0000258595.09320.eb
  48. Sadykova A., Shamkina A. Influence of the hystory of gestational hypertension on total cardiovascular risk in menopausal women. J. Hypertens. 2012; 30 (e-Suppl. A): 243.
  49. Samuels-Kalow M.E., Funai E.F., Buhimschi C. et al. Prepregnancy body mass index, hypertensive disorders of pregnancy, and long-term maternal mortality. Am. J. Obstet. Gynecol. 2007; 197 (5): 490, e1-6.
  50. Savitz D.A., Danilack V.A., Elston B., Lipkind H.S. Pregnancy-induced hypertension and diabetes and the risk of cardiovascular disease, stroke, and diabetes hospitalization in the year following delivery. Am. J. Epidemiol. 2014; 180 (1): 41-44. doi: 10.1093/aje/kwu118
  51. Smith G.C., Pell J.P., Walsh D. Pregnancy complication and maternal risk of ischemic heart disease: a retrospective cohort study of 129 290 births. Lancet. 2001; 357: 2002-2006. doi: 10.1016/S0140-6736(00)05112-6
  52. Valdés G., Quezada F., Marchant E. et al. Association of remote hypertension in pregnancy with coronary artery disease: a case-control study. Hypertension. 2009; 53 (4): 733-778. doi: 10.1161/HYPERTENSIONAHA.108.127068
  53. Vallejo Vaz A.J., Guisado M.L., García-Junco P.S. et al. Differences in the prevalence of metabolic syndrome and levels of C-reactive protein after puerperium in women with hypertensive disorders during pregnancy. Hypertens. Res. 2010; 33 (10): 1012-1017. doi: 10.1038/hr.2010.131
  54. Watanabe K., Kimura C., Iwasaki A. et al. Pregnancy-induced hypertension is associated with an increase in the prevalence of cardiovascular disease risk factors in Japanese women. Menopause. 2015; 22 (6): 656-659. doi: 10.1097/GME.0000000000000361
  55. Wilkins-Haug L., Celi A., Thomas A. et al. Recognition by women’s health care providers of long-term cardiovascular disease risk after preeclampsia. Obstet. Gynecol. 2015; 125 (6): 1287-1292. doi: 10.1097/AOG.0000000000000856
  56. Wilson B.J., Watson M.S., Prescott J.G. et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ. 2003; 326: 845-849. doi: 10.1136/bmj.326.7394.845
  57. Yeh J.S., Cheng H.M., Hsu P.F. et al. Synergistic effect of gestational hypertension and postpartum incident hypertension on cardiovascular health: a nationwide population study. J. Am. Heart Assoc. 2014; 3 (6). doi: 10.1161/JAHA.114.001008
  58. Zhao H.Y., Chen X.W., Niu J.Q. et al. History of pregnancy induced hypertension is linked with increased risk of cardiocerebral vascular events. Zhonghua Xin Xue Guan Bing Za Zhi. 2012; 40 (8): 45-51.

© 2017 Shamkina A.R., Sadykova A.R.

Creative Commons License

This work is licensed
under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies